Empagliflozin ( DrugBank: Empagliflozin )


6 diseases
IDDisease name (Link within this page)Number of trials
58Hypertrophic cardiomyopathy1
65Primary immunodeficiency2
67Polycystic kidney disease1
72Pituitary ADH secretion disorder4
97Ulcerative colitis2
257Hepatic glycogenosis2

58. Hypertrophic cardiomyopathy


Clinical trials : 126Drugs : 135 - (DrugBank : 42) / Drug target genes : 46 - Drug target pathways : 162 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

65. Primary immunodeficiency


Clinical trials : 500Drugs : 614 - (DrugBank : 119) / Drug target genes : 92 - Drug target pathways : 217 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

67. Polycystic kidney disease


Clinical trials : 221Drugs : 212 - (DrugBank : 55) / Drug target genes : 40 - Drug target pathways : 151 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

72. Pituitary ADH secretion disorder


Clinical trials : 41Drugs : 27 - (DrugBank : 8) / Drug target genes : 7 - Drug target pathways : 10 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

97. Ulcerative colitis


Clinical trials : 2,630Drugs : 1,459 - (DrugBank : 265) / Drug target genes : 144 - Drug target pathways : 202 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries

257. Hepatic glycogenosis


Clinical trials : 14Drugs : 27 - (DrugBank : 7) / Drug target genes : 3 - Drug target pathways : 8 
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries